title: Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.
abstract: Studies investigating the pathogenic role of the microtubule associated protein tau (MAPT) gene in Parkinson's disease (PD) have indicated that DNA methylation of the promoter region is aberrant in disease, leading to dysregulated MAPT expression. We examined two potential regulators of MAPT gene expression in respect to PD, a promoter-associated long non-coding RNA MAPT-AS1, and DNA methyltransferases (DNMTs), enzymes responsible for new and maintenance of DNA methylation. We assessed the relationship between expression levels of MAPT and the candidate MAPT-AS1, DNMT1, DNMT3A and DNMT3B transcripts in four brain regions with varying degrees of cell loss and pathology (putamen, anterior cingulate cortex, visual cortex and cerebellum) in N = 10 PD and N = 10 controls. We found a significant decrease in MAPT-AS1 expression in PD (p = 7.154 x 10-6). The transcript levels of both MAPT-AS1 (p = 2.569 x 10-4) and DNMT1 (p = 0.001) correlated with those of MAPT across the four brain regions, but not with each other. Overexpression of MAPT-AS1 decreased MAPT promoter activity by ∼2.2 to 4.3 fold in an in vitro luciferase assay performed in two cell lines (p ≤ 2.678 x 10-4). Knock-down expression of MAPT-AS1 led to a 1.3 to 6.3 fold increase in methylation of the endogenous MAPT promoter (p ≤ 0.011) and a 1.2 to 1.5 fold increased expression of the 4-repeat MAPT isoform transcript (p ≤ 0.013). In conclusion, MAPT-AS1 and DNMT1 have been identified as potential epigenetic regulators of MAPT expression in PD across four different brain regions. Our data also suggest that increased MAPT expression could be associated with disease state, but not with PD neuropathology severity.
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.|School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
authors.forename: Kirsten G
authors.initials: KG
authors.lastname: Coupland
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.|School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
authors.forename: Woojin S
authors.initials: WS
authors.lastname: Kim
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.|School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
authors.forename: Glenda M
authors.initials: GM
authors.lastname: Halliday
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.
authors.forename: Marianne
authors.initials: M
authors.lastname: Hallupp
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.|School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
authors.forename: Carol
authors.initials: C
authors.lastname: Dobson-Stone
authors.affiliation: Neuroscience Research Australia, Randwick, NSW, Australia.|School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
authors.forename: John B J
authors.initials: JB
authors.lastname: Kwok
mesh_terms: D015415:Biomarkers; D001921:Brain / Q000378:metabolism; D019175:DNA Methylation; D005786:Gene Expression Regulation; D006239:Haplotypes; D006801:Humans; D010300:Parkinson Disease / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D062085:RNA, Long Noncoding / Q000235:genetics*; D016875:tau Proteins / Q000235:genetics*
chemical_list: D015415:Biomarkers; C054369:MAPT protein, human; D062085:RNA, Long Noncoding; D016875:tau Proteins